title: Iron acquisition in fungal pathogens of humans.
abstract: The devastating infections that fungal pathogens cause in humans are underappreciated relative to viral, bacterial and parasitic diseases. In recent years, the contributions to virulence of reductive iron uptake, siderophore-mediated uptake and heme acquisition have been identified in the best studied and most life-threatening fungal pathogens: Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. In particular, exciting new work illustrates the importance of iron acquisition from heme and hemoglobin in the virulence of pathogenic yeasts. However, the challenge of establishing how these fungi gain access to hemoglobin in blood and to other sources of heme remains to be fully addressed. Recent studies are also expanding our knowledge of iron uptake in less-well studied fungal pathogens, including dimorphic fungi where new information reveals an integration of iron acquisition with morphogenesis and cell-surface properties for adhesion to host cells. Overall, the accumulating information provides opportunities to exploit iron acquisition for antifungal therapy, and new work highlights the development of specific inhibitors of siderophore biosynthesis and metal chelators for therapeutic use alone or in conjunction with existing antifungal drugs. It is clear that iron-related therapies will need to be customized for specific diseases because the emerging view is that fungal pathogens use different combinations of strategies for iron acquisition in the varied niches of vertebrate hosts.
authors.affiliation: Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. kronstad@msl.ubc.ca.
authors.forename: Gaurav
authors.initials: G
authors.lastname: Bairwa
authors.affiliation: Department of Systems Biotechnology, Chung-Ang University, Anseong, 456-756, Republic of Korea.
authors.forename: Won
authors.initials: W
authors.lastname: Hee Jung
authors.affiliation: Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. kronstad@msl.ubc.ca.
authors.forename: James W
authors.identifier: 0000-0003-4240-6976
authors.initials: JW
authors.lastname: Kronstad
mesh_terms: D000818:Animals; D001228:Aspergillosis / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000302:isolation & purification / Q000378:metabolism* / Q000472:pathogenicity; D003453:Cryptococcosis / Q000382:microbiology; D003455:Cryptococcus neoformans / Q000302:isolation & purification / Q000378:metabolism* / Q000472:pathogenicity; D006801:Humans; D007501:Iron / Q000378:metabolism*; D014774:Virulence
chemical_list: D007501:Iron